Dan Sherbenou, MD, PhD
Hematology
Locations
Practice Locations
UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
720-848-6400
UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus
720-848-0000
Provider Expertise
Clinical Interest for Patients
Multiple myeloma and related plasma cell disorders
Care Philosophy
I have devoted my professional life to understanding what makes cells become cancerous and how to turn that knowledge into the best possible treatments. I seek to empower my patients with knowledge about their disease and its treatments. For me, it is a privilege to provide cancer care and I strive to help patients realize their best possible quality of life.
Specialties
- Hematology ( 2012 )
- Medical Oncology
- Internal Medicine ( 2012 )
Conditions & Treatments
-
Cancers
Blood and Marrow Transplant, Leukemia (Adult Acute), Leukemia (Adult Chronic), Lymphoma, Myeloma
Interests & Activities
Personal Interests
As an undergraduate at the University of Colorado, I started my scientific career focused on basic science research of cancer. In the laboratory of Dr. Min Han, I studied the Ras cell signaling pathway using the C. elegans model organism. In the MD/PhD program at Oregon Health & Science University, I focused on translational leukemia research. Under the mentorship of Drs. Brian Druker and Michael Deininger, I studied chronic myeloid leukemia. My thesis evaluated mechanisms of kinase inhibitor resistance in patients treated with imatinib (Gleevec). In oncology fellowship at University of California at San Francisco, I focused on the study of antibody-based therapeutics under the mentorship of Dr. Bin Liu. Antibody-drug conjugates (ADCs) are another rapidly growing approach to cancer treatment. With Dr. Liu, I conducted preclinical analyses of a novel ADC for multiple myeloma, with hope for this to soon lead to transition to the clinic. Now a faculty member at UC Denver in the Hematology division, I oversee a translational research laboratory focused on novel therapy development and optimization for multiple myeloma and care for patients with myeloma and related plasma cell disorders from Colorado and adjoining areas. In my spare time, I enjoy spending time with my wife and 2 young sons. I love the mountains and spending time outdoors, hiking, road biking, mountain biking and rock climbing.
Education & Training
Medical Schools
MD, Oregon Health & Science University School of Medicine (2009)
Undergraduate Schools
BA, University of Colorado - Boulder (CO) (1999)
Graduate Schools
PhD, Oregon Health And Science University (2009)
Internships
University of Utah Medical Center Program (2010)
Residency Program
University of Utah Medical Center Program (2012)
Fellowships
University of California (San Francisco) Program (2015)
Professional Memberships
American Society of Clinical Oncology (ASCO), Member
American Society of Hematology (ASH), Member
Society for Immunotherapy of Cancer (SITC), Member
Research & Grants
Research Interests for Patients
My lab is located in the blood cancer and bone marrow transplant program of the hematology division of the University of Colorado Anschutz Medical campus. Our research focus is in therapeutic optimization for multiple myeloma, especially for patients with drug resistant and advanced disease. In particular, we are interested in helping develop and apply new immunotherapies to myeloma, especially antibody-based therapies.
information for referring providers
Referral Contact Phone
(720) 848-6400
Clinical Interests for Referring Providers
Multiple myeloma and related plasma cell disorders
Research Interest for Referring Providers
My lab is located in the blood cancer and bone marrow transplant program of the hematology division of the University of Colorado Anschutz Medical campus. Our research focus is in therapeutic optimization for multiple myeloma, especially or patients with drug resistant and advanced disease. In particular, we are interested in helping develop and apply new immunotherapies to myeloma, especially antibody-based therapies.
